Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Immunotherapy for Early Stage Colon Cancer
Recruiting2 awardsPhase 2
Decatur, Illinois
This trial will study the effects of pembrolizumab on early stage colon cancer. The goal is to see if the immunotherapy drug can prevent the cancer from developing resistance.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service